Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients

@article{Kurzawski2006EffectOC,
  title={Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients},
  author={Mateusz Kurzawski and Barbara Gawrońska-Szklarz and Joanna Wrześniewska and Andrzej Siuda and Teresa Starzyńska and Marek Droździk},
  journal={European Journal of Clinical Pharmacology},
  year={2006},
  volume={62},
  pages={877-880}
}
Eradication of Helicobacter pylori is an important treatment strategy in peptic ulcer patients. Current regimens of eradication consist of proton pump inhibitor (PPI) and two antibiotics. The principal enzyme involved in PPIs metabolism is CYP2C19, which exhibits an interindividual variability of activity, mainly due to genetic polymorphism. Two alleles (CYP2C19*2 and CYP2C19*3), responsible for slow PPIs metabolism, were previously associated with higher efficacy of eradication. Recently, a… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 46 extracted citations

Individualized Therapy for Gastroesophageal Reflux Disease

Molecular Diagnosis & Therapy • 2012
View 6 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Table 1 CYP2C19 allele and genotype frequencies in peptic ulcer patients

L Boyanova, A Mentis, +7 authors A Aydin
Eur J Clin Pharmacol • 2006
View 4 Excerpts
Highly Influenced

The status of antimicrobial resistance of Helicobacter pylori in eastern Europe

A Archimandritis, D Dzierzanowska, +6 authors M Popova
Clin Microbiol Infect • 2002

Similar Papers

Loading similar papers…